- Contractors
- Rejuvenate Bio Inc.
Rejuvenate Bio Inc.
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Rejuvenate Bio has 2 federal contracts of $100,000 or more active since October 2023, with $5.14M obligated, from 1 agency. None is running now.
- Contracts
- 2 since FY2024$5,138,889 obligated, contracts of $100,000 or more
- Running now
- None
- Biggest customer
- U.S. Special Operations Command$5.14M on 2 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- GEKFSVSTKK55Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2021 | $2,146,158 |
| FY2022 | $2,992,731 |
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| U.S. Special Operations Command2 contracts | $5,138,889 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts | $5,138,889 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| California2 contracts | $5,138,889 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at U.S. Special Operations Command: see the list.
Get new notices like Rejuvenate Bio's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy